Alnylam Pharmaceuticals
ALNY
#541
Rank
A$64.47 B
Marketcap
A$488.01
Share price
0.31%
Change (1 day)
9.21%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company